0001209191-17-040672.txt : 20170616 0001209191-17-040672.hdr.sgml : 20170616 20170616194512 ACCESSION NUMBER: 0001209191-17-040672 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170615 FILED AS OF DATE: 20170616 DATE AS OF CHANGE: 20170616 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aclaris Therapeutics, Inc. CENTRAL INDEX KEY: 0001557746 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 460571712 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: SUITE 400, 101 LINDENWOOD DRIVE CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 484-321-5554 MAIL ADDRESS: STREET 1: SUITE 400, 101 LINDENWOOD DRIVE CITY: MALVERN STATE: PA ZIP: 19355 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Powell Andrew Kenneth William CENTRAL INDEX KEY: 0001304113 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37581 FILM NUMBER: 17917217 MAIL ADDRESS: STREET 1: C/O COLLAGENEX PHARMACEUTICALS, INC. STREET 2: 41 UNIVERSITY DRIVE CITY: NEWTOWN STATE: PA ZIP: 18940 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-06-15 0 0001557746 Aclaris Therapeutics, Inc. ACRS 0001304113 Powell Andrew Kenneth William C/O ACLARIS THERAPEUTICS, INC. 101 LINDENWOOD DRIVE, SUITE 400 MALVERN PA 19355 1 0 0 0 Stock Option (right to buy) 24.58 2017-06-15 4 A 0 8000 0.00 A 2027-06-14 Common Stock 8000 8000 D The shares underlying this option vest in twelve equal monthly installments through June 15, 2018, subject to the reporting person's continuous service as of such vesting date. /s/ Brian F. Leaf, Attorney-in-Fact 2017-06-16